Best mRNA / LNP CDMOs in United States

· updated as new inspection, certificate, and trial data enters the platform
← All mRNA/LNP CDMOs Best Clean FDA History Commercial Scale
Region: USA Europe Asia UK India Switzerland Germany South Korea Japan China
19
CDMOs tracked
18
Fully scored
13
With FDA records
53
FDA inspections
144
EMA/MHRA GMP certs
2
Warning letters

For US-manufactured mrna / lnp programs, Pfizer CentreOne, Merck KGaA / MilliporeSigma (CDMO), and Moderna (Contract Mfg) lead CDMO Signal's ranking of mrna / lnp CDMOs with confirmed US facilities. Filtered from the global directory of 33 scored mrna / lnp CDMOs to 4 with US manufacturing presence. US-based manufacturing carries specific advantages for sponsors filing under FDA jurisdiction: FDA inspection records — which form the core of the Signal Score's Quality Compliance pillar — apply directly, and QP release complexity common to EU-manufactured material does not apply. Rankings update as new inspection and certificate data enters the platform. Full methodology at cdmosignal.com/methodology.

mRNA and lipid nanoparticle (LNP) manufacturing scaled rapidly after COVID-19 vaccines and now supports therapeutics across rare disease, oncology, and infectious disease. The platform pairs IVT mRNA synthesis with LNP formulation — two distinct capability sets.

Choosing an mRNA/LNP CDMO depends on IVT scale, template strategy (linearized plasmid vs PCR), LNP formulation and microfluidics, and cold-chain handling. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 20 NAI (no action), 31 VAI (voluntary action), 2 OAI (official action). Leading inspection & GMP sites: United States (43), Denmark (29), Germany (26), Italy (21), UNITED KINGDOM (16).

Last updated 2026-10-29. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

# CDMO Signal Score Quality FDA · GMP Capacity Programs
1
PC
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
 87.7 100.0 4 insp · 14 GMP — 366 programs
2
MK
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Hiring · 6 open roles
 81.9 98.8 2 insp · 2 GMP — 22 programs
3
MR
Moderna (Contract Mfg)
Norwood, MA
 77.9 100.0 4 insp · 4 GMP — 10 programs
4
NR
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Hiring · 98+ open roles
 73.6 95.5 1 insp · 0 GMP Available 9 programs
5
FD
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Hiring · 29 open roles
 84.8 100.0 0 insp · 35 GMP Expanding 0 programs
6
WK
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Hiring · 7 open roles
 81.6 100.0 1 insp · 13 GMP — 0 programs
7
EK
Evonik Health Care
Birmingham, AL · Vancouver, BC
 81.5 99.8 2 insp · 2 GMP — 0 programs
8
CD
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
 81.1 99.0 5 insp · 17 GMP — 0 programs
9
ND
Nitto Denko Avecia
Milford, MA
Hiring · 17 open roles
 80.3 100.0 4 insp · 0 GMP — 0 programs
10
AE
Aldevron
Fargo, ND
 80.3 100.0 1 insp · 0 GMP — 0 programs
11
CRA
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Hiring · 41 open roles
 79.5 100.0 2 insp · 18 GMP — 0 programs
12
UM
MassBiologics
Boston, MA
 78.7 96.7 2 insp · 0 GMP — 0 programs
13
DH
Danaher (CGT Portfolio)
Washington, DC
 73.0 — — — 0 programs
14
Catalent
Tampa, FL
Hiring · 296 open roles
 68.6 65.2 24 insp · 39 GMP — 0 programs
15
CG
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
 65.5 — — — 0 programs
16
PBI
ProBio
Pennington, NJ · Nanjing, CN
 64.0 — — — 0 programs
17
TL
TriLink BioTechnologies
San Diego, CA
 63.0 — — — 0 programs
18
AT
Arcturus Therapeutics (Mfg)
San Diego, CA
 60.5 — — — 0 programs
—
Avanti Polar Lipids
Alabaster, Alabama, United States
 Profiled — 1 insp · 0 GMP — 0 programs
How we score CDMOs →

What to evaluate in a mRNA / LNP CDMO

IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.

FDA jurisdiction — how the ranking scores US-based CDMOs

The Signal Score's Quality Compliance pillar (35% of the composite) is dominated by FDA inspection data for US-based CDMOs: Establishment Inspection Report classifications (NAI, VAI, OAI), Form 483 observation counts, and Warning Letter history. For a CDMO whose primary facility footprint is US, this pillar carries direct weight — an inspection on the site slated for a sponsor's program applies without translation. For CDMOs with mixed US + international facility footprint, the ranking reflects the composite regulatory posture; sponsors evaluating for a specific program should verify inspection history on the exact US site under consideration via that CDMO's profile page.

Which US CDMOs also cover EU and UK regulatory geographies?

Many top-tier US-based CDMOs maintain EU (EMA) and UK (MHRA) GMP certification for facilities used to supply EU and UK trials or commercial markets. The Signal Score's Quality Compliance pillar includes EMA + MHRA certificate density as a component — a US-headquartered CDMO with dense EU/UK certificates typically ranks higher on this pillar than a US-only competitor. Sponsors running dual-jurisdiction programs should cross-check the individual CDMO profile pages for specific certificate coverage; the Europe region ranking surfaces CDMOs that also appear in the European jurisdiction ranking, indicating multi-region regulatory posture.

How CDMO Signal identifies US manufacturing presence

Region attribution is derived from each CDMO's declared facility locations in our directory. A CDMO's facility list is validated against corporate filings, press releases, and — where public — the FDA facility registration (FEI number lookups). Region matching is done at the country level: a US state name or two-letter abbreviation in the facility list places the CDMO in the US region. CDMOs with US + international sites appear in every applicable region ranking, which reflects operational reality — such a CDMO is a legitimate candidate for programs in any of those jurisdictions.

mRNA / LNP CDMOs — Frequently Asked Questions

Who are the top mRNA / LNP CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked mRNA / LNP CDMOs include Pfizer CentreOne, Merck KGaA / MilliporeSigma (CDMO), Moderna (Contract Mfg). See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many mRNA / LNP CDMOs have FDA inspection records?
CDMO Signal tracks 13 mRNA / LNP CDMOs with FDA inspection records and 144 EMA/MHRA GMP certificates across the group.
What should I look for in an mRNA / LNP CDMO?
Look for proven IVT mRNA synthesis at your scale, LNP formulation via microfluidics, a clear template/plasmid supply strategy, cold-chain capability, and a clean FDA and EMA/MHRA record.
Do mRNA CDMOs also make the LNP and plasmid?
Capabilities vary. Some CDMOs offer end-to-end IVT mRNA, LNP formulation, and GMP plasmid; others specialize in one step and coordinate partners. Check each profile's modality coverage above.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Save this mRNA/LNP shortlist
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.
Related modalities
Plasmid DNA CDMOs Lentiviral Vector CDMOs AAV / Gene Therapy CDMOs
Other Modalities
AAV CAR-T Lentiviral Cell Therapy Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC Gene Therapy Cell & Gene Therapy Viral Vector